BioCentury | Jun 18, 2015
Distillery Therapeutics

Therapeutics: κ opioid receptor (KOR; OPRK1); opioid receptor δ 1 (OPRD1; DOR)

...S. et al. J. Med. Chem.; published online May 21, 2015 doi:10.1021/jm501637c CONTACT: Adel Nefzi, Torrey Pines Institute for Molecular Studies...
BioCentury | Jul 4, 2011
Company News

GlycoRegImmune, RxMD deal

...to develop type I and type II NK T cell inhibitor technologies from the not-for-profit Torrey Pines Institute for Molecular Studies...
BioCentury | May 24, 2010
Company News

ImmunoCellular, Torrey Pines Institute for Molecular Studies deal

...The terms of the expansion were not disclosed. ImmunoCellular Therapeutics Ltd. (OTCBB:IMUC), Los Angeles, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | Aug 1, 2005
Company News

Catalyst Biosciences, Torrey Pines Institute for Molecular Studies deal

...proteases to treat inflammation and cardiovascular disease. Catalyst Biosciences Inc. , South San Francisco, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | Nov 8, 2004
Company News

Torrey Pines Institute for Molecular Studies other research news

...National Institute of Allergy and Infectious Diseases (NIAID) to conduct research of new smallpox vaccines. Torrey Pines Institute for Molecular Studies...
BioCentury | May 26, 1998
Company News

Torrey Pines Institute for Molecular Studies other research news

...University of California, San Diego, and the Burnham Institute to develop vaccine immunotherapy for cancer. Torrey Pines Institute for Molecular Studies...
BioCentury | Feb 2, 1998
Company News

Trega Biosciences Inc., Torrey Pines Institute for Molecular Studies deal

...compounds using mixture-based peptide and peptidomimetic combinatorial libraries. Trega Biosciences Inc. (TRGA), San Diego, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | May 12, 1997
Company News

Trega Biosciences Inc., Torrey Pines Institute for Molecular Studies deal

...to exclusively license inventions made by the Institute. Trega Biosciences Inc. (TRGA), San Diego, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | Sep 23, 1996
Clinical News

Houghten regulatory update

...the rapid identification of highly active compounds from compound libraries. The patent issued to the Torrey Pines Institute for Molecular Studies...
Items per page:
1 - 9 of 9
BioCentury | Jun 18, 2015
Distillery Therapeutics

Therapeutics: κ opioid receptor (KOR; OPRK1); opioid receptor δ 1 (OPRD1; DOR)

...S. et al. J. Med. Chem.; published online May 21, 2015 doi:10.1021/jm501637c CONTACT: Adel Nefzi, Torrey Pines Institute for Molecular Studies...
BioCentury | Jul 4, 2011
Company News

GlycoRegImmune, RxMD deal

...to develop type I and type II NK T cell inhibitor technologies from the not-for-profit Torrey Pines Institute for Molecular Studies...
BioCentury | May 24, 2010
Company News

ImmunoCellular, Torrey Pines Institute for Molecular Studies deal

...The terms of the expansion were not disclosed. ImmunoCellular Therapeutics Ltd. (OTCBB:IMUC), Los Angeles, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | Aug 1, 2005
Company News

Catalyst Biosciences, Torrey Pines Institute for Molecular Studies deal

...proteases to treat inflammation and cardiovascular disease. Catalyst Biosciences Inc. , South San Francisco, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | Nov 8, 2004
Company News

Torrey Pines Institute for Molecular Studies other research news

...National Institute of Allergy and Infectious Diseases (NIAID) to conduct research of new smallpox vaccines. Torrey Pines Institute for Molecular Studies...
BioCentury | May 26, 1998
Company News

Torrey Pines Institute for Molecular Studies other research news

...University of California, San Diego, and the Burnham Institute to develop vaccine immunotherapy for cancer. Torrey Pines Institute for Molecular Studies...
BioCentury | Feb 2, 1998
Company News

Trega Biosciences Inc., Torrey Pines Institute for Molecular Studies deal

...compounds using mixture-based peptide and peptidomimetic combinatorial libraries. Trega Biosciences Inc. (TRGA), San Diego, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | May 12, 1997
Company News

Trega Biosciences Inc., Torrey Pines Institute for Molecular Studies deal

...to exclusively license inventions made by the Institute. Trega Biosciences Inc. (TRGA), San Diego, Calif. Torrey Pines Institute for Molecular Studies...
BioCentury | Sep 23, 1996
Clinical News

Houghten regulatory update

...the rapid identification of highly active compounds from compound libraries. The patent issued to the Torrey Pines Institute for Molecular Studies...
Items per page:
1 - 9 of 9